Amylin: What might be its role in alzheimer's disease and how could this affect therapy?

Florin Despa, Charles Decarli

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations
Original languageEnglish
Pages (from-to)403-405
Number of pages3
JournalExpert Review of Proteomics
Volume10
Issue number5
DOIs
StatePublished - 2013

Bibliographical note

Funding Information:
F Despa is supported by 1R01HL118474-01A1, NSF CBET-1133339, ADA 1-13-IN-70 and AHA 13GRNT16470034. C DeCarli is supported by NIA P30 AG10129. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Keywords

  • Alzheimer's disease
  • amylin
  • amyloid
  • cerebrovascular disease
  • dementia
  • hyperamylinemia
  • hyperinsulinemia
  • insulin resistance
  • obesity
  • type 2 diabetes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Fingerprint

Dive into the research topics of 'Amylin: What might be its role in alzheimer's disease and how could this affect therapy?'. Together they form a unique fingerprint.

Cite this